MIV Therapeutics gets grant for stenting coating
This article was originally published in Clinica
Executive Summary
MIV Therapeutics, which is developing biocompatible coatings for drug delivery technologies, has gained a Canadian grant that will help it bridge the financial needs associated with its drive to commercialise its technologies.